Grimm E - Search Results

1

Mitochondrial dynamic alterations regulate melanoma cell progression.

Dal Yontem F, Kim SH, Ding Z, Grimm E, Ekmekcioglu S, Akcakaya H. Dal Yontem F, et al. Among authors: grimm e. J Cell Biochem. 2019 Feb;120(2):2098-2108. doi: 10.1002/jcb.27518. Epub 2018 Sep 6. J Cell Biochem. 2019. PMID: 30256441

2

The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10.

Tanese K, Grimm EA, Ekmekcioglu S. Tanese K, et al. Int J Cancer. 2012 Aug 15;131(4):891-901. doi: 10.1002/ijc.26451. Epub 2011 Oct 23. Int J Cancer. 2012. PMID: 21953496 Free PMC article.

3

Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression.

Kim SH, Hashimoto Y, Cho SN, Roszik J, Milton DR, Dal F, Kim SF, Menter DG, Yang P, Ekmekcioglu S, Grimm EA. Kim SH, et al. Pigment Cell Melanoma Res. 2016 May;29(3):297-308. doi: 10.1111/pcmr.12455. Epub 2016 Mar 15. Pigment Cell Melanoma Res. 2016. PMID: 26801201 Free PMC article.

4

Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy.

Kim SH, Roszik J, Grimm EA, Ekmekcioglu S. Kim SH, et al. Front Oncol. 2018 Mar 16;8:67. doi: 10.3389/fonc.2018.00067. eCollection 2018. Front Oncol. 2018. PMID: 29616189 Free PMC article. Review.

5

Loss of MDA-7 expression with progression of melanoma.

Ellerhorst JA, Prieto VG, Ekmekcioglu S, Broemeling L, Yekell S, Chada S, Grimm EA. Ellerhorst JA, et al. J Clin Oncol. 2002 Feb 15;20(4):1069-74. doi: 10.1200/JCO.2002.20.4.1069. J Clin Oncol. 2002. PMID: 11844832

6

Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells.

Zheng M, Ekmekcioglu S, Walch ET, Tang CH, Grimm EA. Zheng M, et al. Melanoma Res. 2004 Jun;14(3):165-71. doi: 10.1097/01.cmr.0000129374.76399.19. Melanoma Res. 2004. PMID: 15179184

7

NO news is not necessarily good news in cancer.

Ekmekcioglu S, Tang CH, Grimm EA. Ekmekcioglu S, et al. Curr Cancer Drug Targets. 2005 Mar;5(2):103-15. doi: 10.2174/1568009053202072. Curr Cancer Drug Targets. 2005. PMID: 15810875 Review.

8

Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis.

Grimm EA, Ellerhorst J, Tang CH, Ekmekcioglu S. Grimm EA, et al. Nitric Oxide. 2008 Sep;19(2):133-7. doi: 10.1016/j.niox.2008.04.009. Epub 2008 Apr 22. Nitric Oxide. 2008. PMID: 18472017 Free PMC article.

9

IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways.

Deng WG, Kwon J, Ekmekcioglu S, Poindexter NJ, Grimm EA. Deng WG, et al. Melanoma Res. 2011 Feb;21(1):44-56. doi: 10.1097/CMR.0b013e3283382155. Melanoma Res. 2011. PMID: 20216471 Free PMC article.

10

Zyflamend mediates therapeutic induction of autophagy to apoptosis in melanoma cells.

Ekmekcioglu S, Chattopadhyay C, Akar U, Gabisi A Jr, Newman RA, Grimm EA. Ekmekcioglu S, et al. Nutr Cancer. 2011;63(6):940-9. doi: 10.1080/01635581.2011.586488. Epub 2011 Jul 11. Nutr Cancer. 2011. PMID: 21745040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page